thinking

Voorspellende geneeskunde

de Vries, G., Horstman, K., Allouche, S., Goffette, J., Marzano, M., Harris, R., … Wyatt, S. (2020). Genetics from laboratory to society. Societal learning as an alternative to regulation. In Webster, Andrew & Wyatt, Sally (Eds.), Health, Technology and Society. Critical inquiries (pp. 91–105). Springer.
Geelen, E., Van Hoyweghen, I., & Horstman, K. (2015). Shaping the future and living in the present: Living a 'good' life with a familial heart disease. BioSocieties, 10, 70–83.
Horstman, K., & Marli Huijer (Eds.). (2013). Gender & genes. Amsterdam: Verloren Publ.
Geelen, E., Van Hoyweghen, I., Doevendans, P. A., Marcelis, C. L. M., & Horstman, K. (2011). Constructing "best interests": Genetic testing of children in families with hypertrophic cardiomyopathy. American Journal of Medical Genetics Part A, 155, 1930–1938.
Aarden, E., Van Hoyweghen, I., & Horstman, K. (2011). The paradox of public health genomics: Definition and diagnosis of familial hypercholesterolaemia in three European countries. Scandinavian Journal of Public Health, 39, 634–639.
Geelen, E., Van Hoyweghen, I., & Horstman, K. (2011). Making genetics not so important: Family work in dealing with familial hypertrophic cardiomyopathy. Social Science & Medicine, 72, 1752–1759.
Horstman, K., & Finkler, K. (2011). Genetics, health care, family and kinship in a global perspective: Situated processes of co-construction. Social Science & Medicine, 72, 1739–1742.
Aarden, E., Van Hoyweghen, I., & Horstman, K. (2011). Constructing access in predictive medicine. Comparing classification for hereditary breast cancer risks in England, Germany and the Netherlands. Social Science & Medicine, 72, 553–559.
Van Hoyweghen, I., & Horstman, K. (2009). Evidence-based underwriting in the molecular age: the politics of reinsurance companies towards the genetics issue. New Genetics and Society, 28, 317–337.
Aarden, E., Van Hoyweghen, I., Vos, R., & Horstman, K. (2009). Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access. Human Reproduction, 24, 1542–1547.
Horstman, K. (2008). Moet alles wat kan? In T. Wiersma (Ed.), Bijblijven. Preconceptionele advisering, diagnostiek en neonatale screening (pp. 64–72).
Horstman, K. (2008). Lifestyle, genes and cholesterol: new struggles about responsibility and solidarity. In G. de Vries, Gerard de & Horstman, Klasien (Eds.), Genetics from laboratory to society. Societal learning as an alternative to regulation (pp. 64–89). Springer.
Vries, G. de, & Horstman, K. (2008). Learning from the work that links laboratory to society. In Vries, Gerard de & Horstman, Klasien (Eds.), Genetics from Laboratory to Society. Societal learning as an alternative to regulations (pp. 171–190). Springer.
Aarden, E., Van Hoyweghen, I., Horstman, K., & Vos, R. (2008). Learning from co-evolution of policy and technology. Different PGDs in the Netherlands, Germany and Britain. Journal of Comparative Policy Analysis: Research and Practice, 10, 191–206.
Horstman, K., & Smand, C. (2008). Detecting familial hypercholesterolaemia: escaping the family history? In Vries, Gerard de & Horstman, Klasien (Eds.), Genetics from Laboratory to Society. Societal learning as an alterantive to regulation (pp. 90–117). Springer.
Hoyweghen, I. van, & Horstman, K. (2008). European Practices of Genetic Information and Insurance. The Journal of the American Medical Association, 300, 326–327.
Vries, G. de, & Horstman, K. (2007). Genetics from laboratory to society: societal learning as an alternative to regulation. Springer.
Van Hoyweghen, I., Horstman, K., & Schepers, R. (2007). Genetic ‘risk carriers’ and lifestyle ‘risk takers’. Which risks deserve our legal protection in insurance? Health Care Analysis, 15, 179–193.
Van Hoyweghen, I., Horstman, K., & Schepers, R. (2006). Making the normal deviant: The introduction of predictive medicine in life insurance. Social Science & Medicine, 63, 1225–1235.
Horstman, K. (2005). From Laboratory to Practice: Learning about normative issues. Converging Technologies. The Hague: STT, 134–155.
Van Hoyweghen, I., Horstman, K., & Schepers, R. (2005). ‘Genetics is not the issue’: Insurers on genetics and life insurance. New Genetics and Society, 24, 79–98.
Geelen, E., Schipper, D., Krumeich, A., & Horstman, K. (2004). Opgelucht, maar ook aangedaan. Ervaringen van vrouwen met risicoschattende testen in de zwangerschap. [Onderzoek voor ZONMW.]. Maastricht: University Maastricht.
Benschop, R., Horstman, K., & Vos, R. (2003). Voice beyond choice: Hesitant voice in public debates about genetics in health care. Health Care Analysis, 11, 141–150.
E.Geelen, K.Horstman, & A.M.Drenthe-Schonk. (1999). Vruchtwaterpunctie: van het besluit tot na de uitslag. Nederlands Tijdschrift voor Obstetrie & Gynaecologie, 112, 32–44.
Horstman, K., De Vries, G. H., & Haveman, O. (1999). Gezondheidspolitiek in een risicocultuur: burgerschap in het tijdperk van de voorspellende geneeskunde. Den HaagRathenau Instituut.
Vries, G. de, Horstman, K., & Haveman, O. (1997). Politiek van preventie. Normatieve aspecten van voorspellende geneeskunde. Werkdocument 58. (p. 88) [Onderzoek in opdracht van het Rathenau Instituut]. Den Haag.